Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
(NASDAQ:NVCT) Fort Lee, NJ, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the develo...
2 days ago